Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 3 4Phase NA 1Phase 2 1

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Conditions

Dupuytren Contracture 4Contracture 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 362Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Interventional × xiapex × Clear all
NCT01407068 2017-10-05

Administration of Two Injections for Multiple Dupuytren's Contractures

Endo Pharmaceuticals

Phase 3 Completed
60 enrolled 12 charts

Dupuytren Contracture

NCT01674634 2017-10-05

Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures

Endo Pharmaceuticals

Phase 3 Completed
715 enrolled 17 charts

Contracture, Dupuytren Contracture

NCT01588353 2017-03-21

CORD-J

Asahi Kasei Therapeutics Corporation

Phase 3 Completed
104 enrolled 13 charts

Dupuytren Contracture

NCT01229436 2014-03-17

POINT X

Pfizer

Phase 3 Completed
254 enrolled 28 charts

Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon âš¡